medline.ch Respirationstrakt Neoplasie

	Development of a deep learning model based on computed tomography automatic segmentation to assist in selecting optimal time-to-surgery and dissected lymph node count for non-small cell lung cancer patients undergoing neoadjuvant immunotherapy and chemotherapy: a multicenter study. Transl Lung Cancer Res Zhao J, Li Y, Chen J, Han C, Yan Y, Zhou C, Bai Y, Xu Y, Li Y. PMID: 41982700 [PubMed]
	Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study. Transl Lung Cancer Res Nomura A, Masuda T, Shimoji K, Takao S, Izumi Y, Araki Y, Takayama Y, Masuda K, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Iwamoto H, Senoo T, Shoda H, Ishikawa N, Yamasaki M, Hamada H, Okada M, Hattori N. PMID: 41982699 [PubMed]
	Lightweight hybrid foundation model for lung cancer prognosis based on low-dose chest X-ray images. Transl Lung Cancer Res Hayeso HH, Lonseko ZM, Alotaibi FMG, Gan T, Shi P, Dong S, Rao N. PMID: 41982697 [PubMed]
	Real-time breath metabolomics as catalyst for personalized lung cancer diagnostics: prospective matched case-control trial (LUCAbreath). Transl Lung Cancer Res Schmidt F, Baur DM, Baumgartner P, Herth J, Fricke K, Sievi NA, Singh KD, Gaisl T, Huang A, Franzen D, Ulrich S, Sinues P, Kohler M. PMID: 41982695 [PubMed]
	Advances in the research on radiotherapy for lung cancer: a 2025 review. Transl Lung Cancer Res Deng J, Zhu Z. PMID: 41982692 [PubMed]
	Adjuvant chemotherapy for completely resected stage IB-IIA non-small cell lung cancer according to the AJCC 8th edition staging system: a real-world retrospective cohort study based on the SEER database. Transl Lung Cancer Res Sun Z, Zhao C, Feng K, Chang G, Zhang J, Ju Y, Yang F, Yan X, Li X. PMID: 41982691 [PubMed]
	Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future directions. Transl Lung Cancer Res Liang X, Li F, Zhang Y, Hu P, Tian T, Zhang Y, Liang N, Deng G, Ding F, Liu X, Qiao L, Zhang J. PMID: 41982689 [PubMed]
	Development and validation of a habitat-based computed tomography radiomics model for differentiating isolated lung cancer, isolated tuberculoma, and coexistence of tuberculosis with lung cancer: a dual-center retrospective study. Transl Lung Cancer Res Shi N, Wan Z, Wen L, Liu Z, Wang B, Li Y, Xiong P, Hou D, Liu X. PMID: 41982687 [PubMed]
	Mediastinal staging and restaging techniques in locally advanced non-small cell lung cancer in the era of neoadjuvant and perioperative chemoimmunotherapy-a narrative review. Transl Lung Cancer Res Izquierdo-Chamarro M, Ospina-Serrano AV, Provencio-Pulla M. PMID: 41982686 [PubMed]
	Neoadjuvant or conversion anti-PD-1/PD-L1 immunotherapy combined with chemotherapy improves 2-year survival and achieves high pathological complete response rate in patients with stage IIB-IIIB small-cell lung cancer. Transl Lung Cancer Res Gao Z, Li Z, Yao X, Shao C, Chen J, Fan Z, Zhao J, Wang J, Ni Y, Xing M, Yan X. PMID: 41982684 [PubMed]
	The 2025 lung cancer landscape: advances in screening, molecular taxonomy and therapeutic strategy: a narrative review. Transl Lung Cancer Res Fu W, Zou X, He T, Cai Q, Chen P, Cheng B, Feng Y, Li C, Li F, Li J, Wang H, Xiong S, Ye W, Zheng X, He J, Liang W. PMID: 41982682 [PubMed]
	Retrospective study of alectinib treatment among variants of ALK fusion in lung adenocarcinoma. Transl Lung Cancer Res Watanabe Y, Takigami A, Hisata S, Nakayama M, Mato N, Maemondo M. PMID: 41982681 [PubMed]
	Influence of chemotherapy intensity on opportunistic fungal infection risk in non-small cell lung carcinoma: a retrospective study. Front Med (Lausanne) Zheng F, Li W, Zhao F, Zhu Z, Wang W, You Q. PMID: 41982541 [PubMed]
	Association Between Red Blood Cell Distribution Width-To-Albumin Ratio and Breast, Colorectal, Lung, and Prostate Cancers. Cancer Med Habibzadeh P, Sorkin J, Hsu D. PMID: 41981727 [PubMed - indexed for MEDLINE]
	The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational study. Cardiooncology Gregorietti V, López-Fernández T, Herrmann J, Costa D, Daniele AJ. PMID: 41981690 [PubMed - as supplied by publisher]
	Targeting MET in non-small cell lung cancer brain metastases: from molecular mechanism to precision therapy. J Transl Med Wang X, Chi Y, Mu F, Mao H, Yang C, Yang M. PMID: 41981677 [PubMed - as supplied by publisher]
	Real-world trends in diagnosis, treatment, and survival of non-small cell lung cancer in Vietnam. BMC Cancer Pham VH, Duong DC, Nguyen VB, Do HN, Nguyen KT, Nguyen TTM, Pham TH, Ngo VL, Nguyen VT, Ho MD, Truong KH, Ho BD, Nguyen VN. PMID: 41981524 [PubMed - as supplied by publisher]
	Industrial point source emissions and incident breast and lung cancers: two case-control studies. Cancer Causes Control Boyle J, Nana-Sinkam P, McGuire KP, Fuemmeler BF. PMID: 41981156 [PubMed - indexed for MEDLINE]
	Deep Learning-Based Tumor Cell Classification in Lung Adenocarcinoma With a Case-by-Case Human-in-the-Loop Approach. APMIS Stampe M, Klausen P, Christiansen IS, Rift CV, Koffeldt PR, Hartvig R, Santoni-Rugiu E, Jensen THL. PMID: 41980857 [PubMed - indexed for MEDLINE]
	Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small cell lung cancer and interstitial lung disease: A multicenter retrospective study. Cancer Treat Res Commun Itoh T, Saito G, Fujimoto K, Ikeda S, Abe M, Hirano S, Nakamura S, Tamiya A, Okishio K, Suzuki T. PMID: 41980497 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 158867

Seite 1 von 7944



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung